Nonpartisan civic infrastructure

H.R. 7667

BillFederalHousePassed House

An Act To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

About This Bill

Passed

Latest Action · June 9, 2022

Received in the Senate.

Congress

117th (2021–2023)

Introduced

May 6, 2022

Sponsor

Rep. Anna EshooD

Cosponsors (3)

1D 2R

View PDF ↗

Summary Full Text Comments Annotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one

No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position

Add a comment

to comment on this bill.

Annotate the text

Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.